Patent

2024

Chun Gwon Park, Wonhwa Lee, “SARS-CoV-2 바이러스 감염증 예방 또는 치료용 약학적 조성물”, No. 10-2021-0119111 (Feburary 22, 2024)

2023

Chun Gwon Park, Wonhwa Lee, “SARS-CoV-2 유도성 패혈증의 진단 또는 예후 예측용 바이오마커 (Biomarkers for diagnosing or predicting prognosis of SARS-CoV-2-induced sepsis)”, No. 10-2021-0038695 (November 2, 2023)

– Dae-Hwan Park, Chun Gwon Park, Se-Na Kim, Min Ji Byun, “피부염에 유효한 층간에 인돌-3-아세트산이 삽입된 금속 이중층 수산화물”, No. 10-2023-0102246 (August 4, 2023)

– Se-Na Kim, Chun Gwon Park, Wooram Park, Hee Seung Seo, “다기능성 키토산 하이드로젤 및 이의 용도”, No. 10-2023-0090490 (July 23, 2023)

– Michael Solomon Goldberg, Chun Gwon Park, “약물 송달 조성물 및 그 사용”, JP 7240311 B2 (March 15, 2023)

– Michael Solomon Goldberg, Chun Gwon Park, “약물 전달 조성물 및 그의 용도”, KR 2497742 B1 (Feburaray 3, 2023)

2022

– Wooram Park, Ha Eun Shin, Chun Gwon Park, “암 치료를 위한 핵산 함유 면역세포막 융합 지질나노입자 (Lipid nanoparticles fused with immune cell membranes containing nucleic acids for cancer treatment)”, No. 10-2022-0043079 (April 7, 2022)

Chun Gwon Park, Wooram Park, Na Kyeong Lee “감염병 및 종양 치료를 위한 면역세포 표적형 유무기 하이브리드 나노입자 (Organic-inorganic Hybrid Nanoparticles Targeting Immune Cells for the Treatment of Infectious Disease and Tumor)”, No. 10-2022-00333691 (March 17, 2022)

2021

Chun Gwon Park, Wonhwa Lee, “SARS-CoV-2 바이러스 감염증 예방 또는 치료용 약학적 조성물 (Pharmaceutical compositions for preventing or treating SARS-CoV-2 infection)”, No. 10-2021-0119111 (September 7, 2021)

– Michael Solomon Goldberg, Chun Gwon Park, “Drug delivery compositions and uses therof”, US 11021539 B2 & EP 3506884 B1 & US 2021-0246211 A1 (June 1 &  May 5 &  April 27, 2021)

Chun Gwon Park, Wonhwa Lee, “SARS-CoV-2-유도성 패혈증의 진단 또는 예후 예측용 바이오마커 (Biomarkers for diagnosing or predicting prognosis of SARS-CoV-2-induced sepsis)”, No. 10-2021-0038695 (March 25, 2021)

2019

– Michael Solomon Goldberg, Chun Gwon Park, “Drug delivery compositions and uses thereof”, US 10435469 B2  & US 10413612 B2 (October 8 & September 17, 2019)

2018

– Michael Solomon Goldberg, Chun Gwon Park, “Drug delivery compositions and uses thereof”, US 10435469 B2  & US 10413612 B2 (November 15, 2018 & August 26, 2019)

2017

– Michael Solomon Goldberg, Chun Gwon Park, “Drug delivery compositions and uses thereof”, PCT Application No. US17/49424 (August 30, 2017)

2014

– Young Bin Choy, Chun Gwon Park, “Mucoadhesive nanoform microparticles”, U.S. Patent Application No. 14/401398 (November 14, 2014)

2013

– Young Bin Choy, Chun Gwon Park, “Mucoadhesive nano-structured microparticles”, Korean Patent Registration No. 10-1511047 (April 6, 2015), PCT Application No. 004252 (May 14, 2013)

– Young Bin Choy, Chun Gwon Park, “Code-mark and manufacturing method, cognition system, cognition method thereof”, Korean Patent Registration No.10-1384612 (April 7, 2014) PCT Application No. 004649 (May 28, 2013)

– Young Bin Choy, Chun Gwon Park, “An esophageal stent for controlled delivery of a drug and a preparation method thereof”, Korean Patent Registration No. 10-1324772 (October 28, 2013)

– Young Bin Choy, Chun Gwon Park, Ji Eun Lee, “Nanofiber sheet-based systems for controlled delivery of oral drugs”, Korean Patent Registration No. 10-1284368 (July 3, 2013)